CA2650368A1 - Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques - Google Patents

Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques Download PDF

Info

Publication number
CA2650368A1
CA2650368A1 CA2650368A CA2650368A CA2650368A1 CA 2650368 A1 CA2650368 A1 CA 2650368A1 CA 2650368 A CA2650368 A CA 2650368A CA 2650368 A CA2650368 A CA 2650368A CA 2650368 A1 CA2650368 A1 CA 2650368A1
Authority
CA
Canada
Prior art keywords
agent
treating
mcm
preventing osteoporosis
mineral complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2650368A
Other languages
English (en)
Inventor
Takeshi Ogura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2650368A priority Critical patent/CA2650368A1/fr
Publication of CA2650368A1 publication Critical patent/CA2650368A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2650368A 2009-01-22 2009-01-22 Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques Abandoned CA2650368A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2650368A CA2650368A1 (fr) 2009-01-22 2009-01-22 Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2650368A CA2650368A1 (fr) 2009-01-22 2009-01-22 Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques

Publications (1)

Publication Number Publication Date
CA2650368A1 true CA2650368A1 (fr) 2010-07-22

Family

ID=42352537

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2650368A Abandoned CA2650368A1 (fr) 2009-01-22 2009-01-22 Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques

Country Status (1)

Country Link
CA (1) CA2650368A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207411A1 (fr) * 2015-06-24 2016-12-29 Oriel Seasalt Company Limited Extrait minéral d'eau de mer hautement concentré et utilisations associées

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016207411A1 (fr) * 2015-06-24 2016-12-29 Oriel Seasalt Company Limited Extrait minéral d'eau de mer hautement concentré et utilisations associées
US20180177714A1 (en) * 2015-06-24 2018-06-28 Oriel Seasalt Company Limited A highly concentrated seawater mineral extract and uses thereof
US11752088B2 (en) * 2015-06-24 2023-09-12 Oriel Seasalt Company Limited Highly concentrated seawater mineral extract and uses thereof
AU2021236518B2 (en) * 2015-06-24 2023-11-09 Oriel Seasalt Company Limited A highly concentrated seawater mineral extract and uses thereof

Similar Documents

Publication Publication Date Title
THORPE et al. Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half years
KR20220137663A (ko) 청폐배독 기능이 있는 중약 복합 처방 및 그 용도
RU2001110097A (ru) Терапевтические композиции (ii)
HU226984B1 (en) Medical and food products for treating diabetes mellitus and process for producing thereof
JP3247620B2 (ja) 海洋ミネラル成分からなる治療及び／または予防剤
JP2008013469A (ja) 海洋ミネラル成分からなる骨粗鬆症治療および／または予防剤
WO2007109587A2 (fr) Compositions et procédés permettant de réduire l'inflammation et la douleur associées à l'acidose
CN104703486A (zh) 富含柠檬酸根的钙-镁补充剂及其用途
US20100189812A1 (en) Agent for treating and/or preventing osteoporosis, comprising oceanic mineral components
CA2650368A1 (fr) Agent pour le traitement et/ou la prevention de l'osteoporose comprenant des composants a base de mineraux oceaniques
JPS6154389B2 (fr)
GB2522283A (en) Traditional chinese medicine composition for the treatment of diabetes
CN110742902A (zh) 一种锂离子组合物及其应用
KR100793815B1 (ko) 유황의 독성을 제거하는 방법
JPH06199695A (ja) 糖尿病改善治療剤
WO1996038058A1 (fr) Composition contenant du calcium facilement absorbable et son procede de fabrication
Panda et al. Fluoride and its health impacts-a critical review
KR101068973B1 (ko) 유황의 유해성분을 제거하는 방법
JP2005343862A (ja) ミネラル含有剤とその用途
JPS61109730A (ja) 尿路に発生する結石の予防叉は治療に使用する薬剤
CN1120725C (zh) 治疗骨质疏松、增生的药物及其制备方法
JP2008094762A (ja) 海洋ミネラル成分からなるｎｋ細胞活性化剤
WO2021100837A1 (fr) Composition permettant la prévention ou la réduction de l'hyperuricémie, et procédé de production d'une telle composition
KR100526639B1 (ko) 위암에 대한 항암 및 제암 효과를 갖는 건강보조식품 및 이의 제조방법
TW460285B (en) A process for preparing calcium containing composition with high oral bioavailability

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20130122